Magazine
Subscribe
Submit Press Release
Issue Archives
Virtual Issue Archives
Special Sections
Reprints
NJBT E-News
About / Sign Up
Submit Press Release
Archives
NJB News Now
Sponsored Content
Industries
Accounting
Banking / Financial
Coronavirus
Economic Development
Energy
Environment
General Business
Government
Healthcare
High-Tech
Higher Ed
Infrastructure
Law
Meeting Places
Real Estate
Science & Technology
Small Business
Tourism
Workforce Development
Advertising
Upcoming Opportunities
Media Kit Request
File Upload
Ad Orbit Login
Awards
Awards for Excellence Nomination
2024 New Good Neighbor Nomination Form
About
NJB Magazine
NJBIA
Contact
Daily E-News Sign Up
Subscribe
Blog
Twitter
Facebook
Google
Linkedin
Magazine
Subscribe
Submit Press Release
Issue Archives
Virtual Issue Archives
Special Sections
Reprints
NJBT E-News
About / Sign Up
Submit Press Release
Archives
NJB News Now
Sponsored Content
Industries
Accounting
Banking / Financial
Coronavirus
Economic Development
Energy
Environment
General Business
Government
Healthcare
High-Tech
Higher Ed
Infrastructure
Law
Meeting Places
Real Estate
Science & Technology
Small Business
Tourism
Workforce Development
Advertising
Upcoming Opportunities
Media Kit Request
File Upload
Ad Orbit Login
Awards
Awards for Excellence Nomination
2024 New Good Neighbor Nomination Form
About
NJB Magazine
NJBIA
Contact
Tag
Johnson & Johnson
Johnson & Johnson Launches Network of Global Health Discovery Centers
Corporate Philanthropy Supplements NJ’s Pandemic Recovery
Johnson & Johnson COVID-19 Vaccine Rollout to Resume in Europe
J&J Vaccine Pause Will Not Affect Full Eligibility Opening Next Week
Health Commissioner Persichilli Issues Statement on J&J Vaccine Halt
Vaccine Rollout Will be Hindered by Supply Chain Disruption
J&J Announces Advance Purchase Agreement with the African Vaccine Acquisition Trust
J&J Single-Shot COVID-19 Vaccine Granted Emergency Use Listing by WHO
First Residents Receive the Johnson & Johnson Vaccine
Merck to Team Up with J&J in Vaccine Production
J&J Submits COVID-19 Vaccine Candidate for Emergency Use Listing
Janssen COVID-19 Vaccine Candidate 72% Effective in US Trials
J&J, HHS Expand Agreement on Next Phase of COVID-19 Vaccine Research
J&J Pauses COVID-19 Vaccine Clinical Trials
J&J to Supply 200M Doses of COVID-19 Vax Candidate
J&J to Acquire Momenta Pharmaceuticals
J&J Announces Agreement for 100M Doses of Investigational COVID-19 Vaccine
Catalent Signs Agreement to Manufacture Lead COVID-19 Vaccine Candidate
J&J to Expand Manufacturing Capabilities for COVID-19 Vaccine Candidate
Johnson & Johnson Launches ‘The Road to a Vaccine’ Series
J&J Announces Lead Vaccine Candidate for COVID-19
J&J to Expand Partnership to Find Coronavirus Treatments
J&J Collaboration Aims to Develop Coronavirus Vaccine
J&J Launches Multi-Pronged Response to Coronavirus
« Previous
1
2
3
Next »
Articles by Industry
Accounting
Banking / Financial
Coronavirus
Diversity
Economic Development
Economy
Energy
Environment
General Business
Government
Healthcare
High-Tech
Higher Ed
Infrastructure
Labor
Law
Life Sciences
Manufacturing
Meeting Places
New Hire/Promotion
Philanthropy
Real Estate
Science & Technology
Small Business
Tourism
Workforce Development
Special Sections
Sponsored Content
NEW JERSEY BUSINESS TODAY!
Join our Daily E-News Service
Email
(Required)
First Name
(Required)
Last Name
(Required)
Company
(Required)
Name
This field is for validation purposes and should be left unchanged.
Δ